#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma recurrent Angiosarcoma recurrent Congenital disorder of glycosylation Conjunctivitis allergic Alagille syndrome Nodal marginal zone B-cell lymphoma Myelin oligodendrocyte glycoprotein antibody-associated disease Monogenic diabetes Still's disease Neuropathic arthropathy Netherton's syndrome Severe myoclonic epilepsy of infancy Pouchitis Enteritis Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Treatment Mast cell activation syndrome – Basic Information Idiopathic inflammatory myopathy – Life with Disease Systemic sclerosis pulmonary – Basic Information Pelizaeus-Merzbacher disease – Life with Disease Hepatic angiosarcoma – Life with Disease Soft tissue sarcoma – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Hyperoxaluria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    F44/10 Rifaximin Propafenone Hydrochloride Niraparib Chlorpromazine Hydrochloride Avalotcagene Ontaparvovec Belantamab Mafodotin Mb-Cart20.1 Sacubitril Bi 764532 Emtricitabine Sodium Acetate Trihydrate Ilofotase Alfa Bms-986315 VELPATASVIR TAGRAXOFUSP MOLNUPIRAVIR Cyanocobalamin Tildacerfont Atrasentan Hydrochloride More therapies…

    Learn about Your Condition

    Otitis media Dizziness Hepatorenal syndrome Acute HIV infection Habitual abortion Primary hyperaldosteronism Medication overuse headache Bronchostenosis Malignant fibrous histiocytoma Partial seizures Cervix carcinoma stage I Metastases to peritoneum Rheumatic disorder Breast neoplasm Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effectiveness of Venetoclax with Fludarabine, Amsacrine, and Cytarabine for Patients with MDS, CMML, or Secondary AML Undergoing Stem Cell Transplantation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Leukaemia
    Investigated Drugs:
    • Amsacrine
    • Febuxostat Hemihydrate
    • Rasburicase
    Germany

  • Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Premature rupture of membranes
    Investigated Drugs:
    • Nifedipine
    France

  • Study on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Mite allergy
    • Rhinitis allergic
    Investigated Drugs:
    • Dermatophagoides Farinae Extract
    • Dermatophagoides Pteronyssinus Extract
    Portugal Spain

  • Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Czechia France Germany Italy The Netherlands +2

  • Long-Term Safety Study of Gene Therapy with Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Wiskott-Aldrich syndrome
    Investigated Drugs:
    • Etuvetidigene Autotemcel
    France

  • Study of Ezabenlimab and Drug Combination for Stage III Anal Cancer Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    Investigated Drugs:
    • Ezabenlimab
    • Mitomycin
    • Capecitabine
    France
Previous Page
1 … 322 323 324 325 326 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!